The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Structure-based discovery of opioid analgesics with reduced side effects
Open accessAbstract
Morphine is an alkaloid from the opium poppy used to treat pain. The potentially lethal side effects of morphine and related opioids—which include fatal respiratory depression—are thought to be mediated by μ-opioid-receptor (μOR) signalling through the β-arrestin pathway or by actions at other receptors. Conversely, G-protein μOR signalling is thought to confer analgesia. Here we computationally dock over 3 million molecules against the μOR structure and identify new scaffolds unrelated to known opioids. Structure-based optimization yields PZM21—a potent Gi activator with exceptional selectivity for μOR and minimal β-arrestin-2 recruitment. Unlike morphine, PZM21 is more efficacious for the affective component of analgesia versus the reflexive component and is devoid of both respiratory depression and morphine-like reinforcing activity in mice at equi-analgesic doses. PZM21 thus serves as both a probe to disentangle μOR signalling and a therapeutic lead that is devoid of many of the side effects of current opioids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development and testing of a general amber force field
Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20035 · Cited by 19,506
The missing term in effective pair potentials
Berendsen, H. J. C., Grigera, J. R., & Straatsma, T. P. (1987) · The Journal of Physical Chemistry · doi:10.1021/j100308a038 · Cited by 13,345
Bayly, C. I., Cieplak, P., Cornell, W., & Kollman, P. A. (1993) · The Journal of Physical Chemistry · doi:10.1021/j100142a004 · Cited by 8,081
Comparison of multiple Amber force fields and development of improved protein backbone parameters
Hornak, V., Abel, R., Okur, A., Strockbine, B., Roitberg, A., & Simmerling, C. (2006) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.21123 · Cited by 6,914
The Behavior of Organisms: An Experimental Analysis
Jones, F. N., & Skinner, B. F. (1939) · The American Journal of Psychology · doi:10.2307/1416495 · Cited by 4,398
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
Identification of two related pentapeptides from the brain with potent opiate agonist activity
Hughes, J., Smith, T. W., Kosterlitz, H. W., Fothergill, L. A., Morgan, B. A., & Morris, H. R. (1975) · Nature · doi:10.1038/258577a0 · Cited by 3,806
Ballesteros, J. A., & Weinstein, H. (1995) · Methods in Neurosciences · doi:10.1016/s1043-9471(05)80049-7 · Cited by 2,999
Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., & Gilbert, P. E. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30536-7 · Cited by 2,992
ZINC: A Free Tool to Discover Chemistry for Biology
Irwin, J. J., Sterling, T., Mysinger, M. M., Bolstad, E. S., & Coleman, R. G. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci3001277 · Cited by 2,509
Endogenous opioid peptides: multiple agonists and receptors
Lord, J. A. H., Waterfield, A. A., Hughes, J., & Kosterlitz, H. W. (1977) · Nature · doi:10.1038/267495a0 · Cited by 2,485
The formalin test in mice: dissociation between inflammatory and non-inflammatory pain
Hunskaar, S., & Hole, K. (1987) · Pain · doi:10.1016/0304-3959(87)90088-1 · Cited by 2,186
Rácz, I., & Zimmer, A. (2006) · Standards of Mouse Model Phenotyping · doi:10.1002/9783527611942.ch9 · Cited by 1,659
Species-specific defense reactions and avoidance learning
Bolles, R. C. (1970) · Psychological Review · doi:10.1037/h0028589 · Cited by 1,610
Le Bars, D., Gozariu, M., & Cadden, S. W. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01514-x · Cited by 1,459
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist
Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Mathiesen, J. M., Sunahara, R. K., Pardo, L., Weis, W. I., Kobilka, B. K., & Granier, S. (2012) · Nature · doi:10.1038/nature10954 · Cited by 1,356
Self-citationSome quantitative properties of anxiety.
Estes, W. K., & Skinner, B. F. (1941) · Journal of Experimental Psychology · doi:10.1037/h0062283 · Cited by 1,349
Tzschentke, T. M. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00060-4 · Cited by 1,266
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
Bohn, L. M., Lefkowitz, R. J., Gainetdinov, R. R., Peppel, K., Caron, M. G., & Lin, F.-T. (1999) · Science · doi:10.1126/science.286.5449.2495 · Cited by 1,077
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.
Spanagel, R., Herz, A., & Shippenberg, T. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2046 · Cited by 1,014
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
Bohn, L. M., Gainetdinov, R. R., Lin, F.-T., Lefkowitz, R. J., & Caron, M. G. (2000) · Nature · doi:10.1038/35047086 · Cited by 927
Olfactory exposure to males, including men, causes stress and related analgesia in rodents
Sorge, R. E., Martin, L. J., Isbester, K. A., Sotocinal, S. G., Rosen, S., Tuttle, A. H., Wieskopf, J. S., Acland, E. L., Dokova, A., Kadoura, B., et al. (2014) · Nature Methods · doi:10.1038/nmeth.2935 · Cited by 905
Structural insights into µ-opioid receptor activation
Huang, W., Manglik, A., Venkatakrishnan, A. J., Laeremans, T., Feinberg, E. N., Sanborn, A. L., Kato, H. E., Livingston, K. E., Thorsen, T. S., Kling, R. C., et al. (2015) · Nature · doi:10.1038/nature14886 · Cited by 885
Self-citationStructure of the human κ-opioid receptor in complex with JDTic
Wu, H., Wacker, D., Mileni, M., Katritch, V., Han, G. W., Vardy, E., Liu, W., Thompson, A. A., Huang, X.-P., Carroll, F. I., et al. (2012) · Nature · doi:10.1038/nature10939 · Cited by 879
Self-citationAutomated design of ligands to polypharmacological profiles
Besnard, J., Ruda, G. F., Setola, V., Abecassis, K., Rodriguiz, R. M., Huang, X.-P., Norval, S., Sassano, M. F., Shin, A. I., Webster, L. A., et al. (2012) · Nature · doi:10.1038/nature11691 · Cited by 832
Self-citationA perceptual-defensive-recuperative model of fear and pain
Bolles, R. C., & Fanselow, M. S. (1980) · Behavioral and Brain Sciences · doi:10.1017/s0140525x0000491x · Cited by 832
PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Kroeze, W. K., Sassano, M. F., Huang, X.-P., Lansu, K., McCorvy, J. D., Giguère, P. M., Sciaky, N., & Roth, B. L. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3014 · Cited by 755
Self-citationSignalling bias in new drug discovery: detection, quantification and therapeutic impact
Kenakin, T., & Christopoulos, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3954 · Cited by 740
Structure of the δ-opioid receptor bound to naltrindole
Granier, S., Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Weis, W. I., & Kobilka, B. K. (2012) · Nature · doi:10.1038/nature11111 · Cited by 667
Self-citationDeWire, S. M., Yamashita, D. S., Rominger, D. H., Liu, G., Cowan, C. L., Graczyk, T. M., Chen, X.-T., Pitis, P. M., Gotchev, D., Yuan, C., et al. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201616 · Cited by 647
Morphine Side Effects in β-Arrestin 2 Knockout Mice
Raehal, K. M., Walker, J. K. L., & Bohn, L. M. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087254 · Cited by 626
Mu Opioids and Their Receptors: Evolution of a Concept
Pasternak, G. W., & Pan, Y.-X. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007138 · Cited by 578
Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic
Thompson, A. A., Liu, W., Chun, E., Katritch, V., Wu, H., Vardy, E., Huang, X.-P., Trapella, C., Guerrini, R., Calo, G., et al. (2012) · Nature · doi:10.1038/nature11085 · Cited by 477
Self-citationElucidating an Affective Pain Circuit that Creates a Threat Memory
Han, S., Soleiman, M. T., Soden, M. E., Zweifel, L. S., & Palmiter, R. D. (2015) · Cell · doi:10.1016/j.cell.2015.05.057 · Cited by 454
Passive and active reactions to fear-eliciting stimuli.
Blanchard, R. J., & Blanchard, D. C. (1969) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0027676 · Cited by 413
Quantifying Ligand Bias at Seven-Transmembrane Receptors
Rajagopal, S., Ahn, S., Rominger, D. H., Gowen-MacDonald, W., Lam, C. M., DeWire, S. M., Violin, J. D., & Lefkowitz, R. J. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.072801 · Cited by 388
The catalepsy test: Its ups and downs.
Sanberg, P. R., Bunsey, M. D., Giòrdano, M., & Norman, A. B. (1988) · Behavioral Neuroscience · doi:10.1037//0735-7044.102.5.748 · Cited by 375
Jiang, L. I., Collins, J., Davis, R., Lin, K.-M., DeCamp, D., Roach, T., Hsueh, R., Rebres, R. A., Ross, E. M., Taussig, R., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609695200 · Cited by 358
Inhibition of avoidance behavior.
Rescorla, R. A., & Lolordo, V. M. (1965) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0022060 · Cited by 323
Rapid Context-Dependent Ligand Desolvation in Molecular Docking
Mysinger, M. M., & Shoichet, B. K. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100214a · Cited by 317
Self-citationLigand discovery from a dopamine D3 receptor homology model and crystal structure
Carlsson, J., Coleman, R. G., Setola, V., Irwin, J. J., Fan, H., Schlessinger, A., Sali, A., Roth, B. L., & Shoichet, B. K. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.662 · Cited by 308
Self-citationStructure-based discovery of β 2 -adrenergic receptor ligands
Kolb, P., Rosenbaum, D. M., Irwin, J. J., Fung, J. J., Kobilka, B. K., & Shoichet, B. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812657106 · Cited by 288
Self-citationAutomated Docking Screens: A Feasibility Study
Irwin, J. J., Shoichet, B. K., Mysinger, M. M., Huang, N., Colizzi, F., Wassam, P., & Cao, Y. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9006966 · Cited by 286
Self-citationAllosteric ligands for the pharmacologically dark receptors GPR68 and GPR65
Huang, X.-P., Karpiak, J., Kroeze, W. K., Zhu, H., Chen, X., Moy, S. S., Saddoris, K. A., Nikolova, V. D., Farrell, M. S., Wang, S., et al. (2015) · Nature · doi:10.1038/nature15699 · Cited by 284
Self-citationWoolf, C. J. (1984) · Pain · doi:10.1016/0304-3959(84)90045-9 · Cited by 278
Soergel, D. G., Subach, R. A., Burnham, N., Lark, M. W., James, I. E., Sadler, B. M., Skobieranda, F., Violin, J. D., & Webster, L. R. (2014) · Pain · doi:10.1016/j.pain.2014.06.011 · Cited by 262
Structure-Based Discovery of Novel Chemotypes for Adenosine A2AReceptor Antagonists
Katritch, V., Jaakola, V.-P., Lane, J. R., Lin, J., IJzerman, A. P., Yeager, M., Kufareva, I., Stevens, R. C., & Abagyan, R. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901647p · Cited by 245
Structure-Based Discovery of A 2A Adenosine Receptor Ligands
Carlsson, J., Yoo, L., Gao, Z.-G., Irwin, J. J., Shoichet, B. K., & Jacobson, K. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100240h · Cited by 227
Self-citationGroer, C. E., Tidgewell, K., Moyer, R. A., Harding, W. W., Rothman, R. B., Prisinzano, T. E., & Bohn, L. M. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.028258 · Cited by 224
Estes, W. K. (1948) · Journal of Experimental Psychology · doi:10.1037/h0057525 · Cited by 210
Enhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice
Bohn, L. M., Gainetdinov, R. R., Sotnikova, T. D., Medvedev, I. O., Lefkowitz, R. J., Dykstra, L. A., & Caron, M. G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-32-10265.2003 · Cited by 210
Gogas, K. R., Presley, R. W., Levine, J. D., & Basbaum, A. I. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90031-i · Cited by 206
de Graaf, C., Kooistra, A. J., Vischer, H. F., Katritch, V., Kuijer, M., Shiroishi, M., Iwata, S., Shimamura, T., Stevens, R. C., de Esch, I. J. P., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2011589 · Cited by 204
Structural basis for bifunctional peptide recognition at human δ-opioid receptor
Fenalti, G., Zatsepin, N. A., Betti, C., Giguere, P., Han, G. W., Ishchenko, A., Liu, W., Guillemyn, K., Zhang, H., James, D., et al. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2965 · Cited by 180
Self-citationHübner, H., Haubmann, C., Utz, W., & Gmeiner, P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm991098z · Cited by 170
Self-citationLi, C., Sugam, J. A., Lowery-Gionta, E. G., McElligott, Z. A., McCall, N. M., Lopez, A. J., McKlveen, J. M., Pleil, K. E., & Kash, T. L. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.12 · Cited by 161
Application of Belief Theory to Similarity Data Fusion for Use in Analog Searching and Lead Hopping
Muchmore, S. W., Debe, D. A., Metz, J. T., Brown, S. P., Martin, Y. C., & Hajduk, P. J. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci7004498 · Cited by 160
Identification of Novel Adenosine A2A Receptor Antagonists by Virtual Screening
Langmead, C. J., Andrews, S. P., Congreve, M., Errey, J. C., Hurrell, E., Marshall, F. H., Mason, J. S., Richardson, C. M., Robertson, N. J., Zhukov, A., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201455y · Cited by 145
G-protein–gated Inwardly Rectifying Potassium Channels Modulate Respiratory Depression by Opioids
Montandon, G., Ren, J. T., Victoria, N. C., Liu, H., Wickman, K., Greer, J. J., & Horner, R. L. (2015) · Anesthesiology · doi:10.1097/aln.0000000000000984 · Cited by 135
Structure-based ligand discovery for the protein–protein interface of chemokine receptor CXCR4
Mysinger, M. M., Weiss, D. R., Ziarek, J. J., Gravel, S., Doak, A. K., Karpiak, J. D., Heveker, N., Shoichet, B. K., & Volkman, B. F. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120431109 · Cited by 132
Self-citationStructure-Based Discovery of a Novel, Noncovalent Inhibitor of AmpC β-Lactamase
Powers, R. A., Morandi, F., & Shoichet, B. K. (2002) · Structure · doi:10.1016/s0969-2126(02)00799-2 · Cited by 121
Self-citationAcute Tolerance in Morphine Analgesia
Kissin, I., Brown, P. T., Robinson, C. A., & Bradley, E. L. (1991) · Anesthesiology · doi:10.1097/00000542-199101000-00025 · Cited by 116
Weiss, D. R., Ahn, S., Sassano, M. F., Kleist, A. B., Zhu, X., Strachan, R. T., Roth, B. L., Lefkowitz, R. J., & Shoichet, B. K. (2013) · ACS Chemical Biology · doi:10.1021/cb400103f · Cited by 113
Self-citationChronic Social Stress and Susceptibility to Concentrated Ambient Fine Particles in Rats
Clougherty, J. E., Rossi, C. A., Lawrence, J. E., Long, M. S., Diaz, E. A., Lim, R. H., McEwen, B. S., Koutrakis, P., & Godleski, J. J. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901631 · Cited by 100
Covalent agonists for studying G protein-coupled receptor activation
Weichert, D., Kruse, A. C., Manglik, A., Hiller, C., Zhang, C., Hübner, H., Kobilka, B. K., & Gmeiner, P. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410415111 · Cited by 97
Self-citationHuang, X., Mangano, T. J., Hufeisen, S., Setola, V., & Roth, B. L. (2010) · Assay and Drug Development Technologies · doi:10.1089/adt.2010.0331 · Cited by 86
Self-citationFunctionally Selective Dopamine D 2 , D 3 Receptor Partial Agonists
Möller, D., Kling, R. C., Skultety, M., Leuner, K., Hübner, H., & Gmeiner, P. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5004039 · Cited by 80
Self-citationNegri, A., Rives, M., Caspers, M. J., Prisinzano, T. E., Javitch, J. A., & Filizola, M. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400019t · Cited by 66
Functionally Selective Dopamine D2/D3Receptor Agonists Comprising an Enyne Moiety
Hiller, C., Kling, R. C., Heinemann, F. W., Meyer, K., Hübner, H., & Gmeiner, P. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400520c · Cited by 55
Self-citationGoetz, A., Lanig, H., Gmeiner, P., & Clark, T. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.10.015 · Cited by 34
Self-citationThermal sensitivity as a measure of spontaneous morphine withdrawal in mice
Balter, R. E., & Dykstra, L. (2013) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2013.02.003 · Cited by 23
Co-Expression of GRK2 Reveals a Novel Conformational State of the µ-Opioid Receptor
Nickolls, S. A., Humphreys, S., Clark, M., & McMurray, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083691 · Cited by 17
Designer Receptors Exclusively Activated by Designer Drugs
(2015) · Neuromethods · doi:10.1007/978-1-4939-2944-3 · Cited by 9
Cited by
Molecular Dynamics Simulation for All
Hollingsworth, S. A., & Dror, R. O. (2018) · Neuron · doi:10.1016/j.neuron.2018.08.011 · Cited by 3,257
Trends in GPCR drug discovery: new agents, targets and indications
Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schiöth, H. B., & Gloriam, D. E. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.178 · Cited by 2,627
Poorly controlled postoperative pain: prevalence, consequences, and prevention
Gan, T. J. (2017) · Journal of Pain Research · doi:10.2147/jpr.s144066 · Cited by 1,489
Computational approaches streamlining drug discovery
Sadybekov, A. V., & Katritch, V. (2023) · Nature · doi:10.1038/s41586-023-05905-z · Cited by 1,279
Ultra-large library docking for discovering new chemotypes
Lyu, J., Wang, S., Balius, T. E., Singh, I., Levit, A., Moroz, Y. S., O’Meara, M. J., Che, T., Algaa, E., Tolmachova, K., et al. (2019) · Nature · doi:10.1038/s41586-019-0917-9 · Cited by 998
Self-citation
Metadata
- Authors
- Manglik, A., Lin, H., Aryal, D. K., McCorvy, J. D., Dengler, D., Corder, G., Levit, A., Kling, R. C., Bernat, V., Hübner, H., Huang, X.-P., Sassano, M. F., Giguère, P. M., Löber, S., Duan, D., Scherrer, G., Kobilka, B. K., Gmeiner, P., Roth, B. L., & Shoichet, B. K.
- Venue
- Nature
- Published
- 2016-08-17
- Volume
- 537
- Issue
- 7619
- Pages
- 185-190
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2512819857
- Cited by
- 944
- References
- 73
- FWCI
- 56.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.